138 related articles for article (PubMed ID: 23493241)
1. SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province.
Bandegi AR; Firoozrai M; Akbari Eidgahi MR; Kokhaei P
Iran J Basic Med Sci; 2011 Nov; 14(6):506-13. PubMed ID: 23493241
[TBL] [Abstract][Full Text] [Related]
2. [Association Between Apolipoprotein C-3
Tang F; Bai H; Guan L; Liu X; Fan P; Zhou M; Wu Y; Liu S; Wang Y; Li D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):994-999. PubMed ID: 37866958
[TBL] [Abstract][Full Text] [Related]
3. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism.
Espino-Montoro A; Barrios-Artillo M; López-Chozas JM; Cayuela A; Stiefel P; Villar J
Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):194-201. PubMed ID: 14650351
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians.
Chhabra S; Narang R; Krishnan LR; Vasisht S; Agarwal DP; Srivastava LM; Manchanda SC; Das N
BMC Genet; 2002 Jun; 3():9. PubMed ID: 12052247
[TBL] [Abstract][Full Text] [Related]
5. Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.
Huang MC; Wang TN; Liu YL; Pa TH; Tu HP; Huang YC; Chang WT; Ko YC
Circ J; 2006 Aug; 70(8):1030-6. PubMed ID: 16864937
[TBL] [Abstract][Full Text] [Related]
6. [Apolipoprotein C III gene Sst I polymorphism in patients with endogenous hypertriglyceridemia in Chinese population].
Liu R; Bai H; Liu Y; Huang M; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):175-8, 190. PubMed ID: 12600077
[TBL] [Abstract][Full Text] [Related]
7. Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease.
Wick U; Witt E; Engel W
Clin Genet; 1995 Apr; 47(4):184-90. PubMed ID: 7628120
[TBL] [Abstract][Full Text] [Related]
8. Variation in the apo AI/CIII/AIV gene complex: its association with hyperlipidemia.
Shoulders CC; Ball MJ; Baralle FE
Atherosclerosis; 1989 Dec; 80(2):111-8. PubMed ID: 2514696
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein CIII polymorphism and triglyceride levels of a Japanese population living in Southern Brazil.
Parzianello L; Oliveira G; Coelho JC
Braz J Med Biol Res; 2008 Jun; 41(6):462-7. PubMed ID: 18560672
[TBL] [Abstract][Full Text] [Related]
10. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index.
Wu JH; Kao JT; Wen MS; Lo SK
J Formos Med Assoc; 2000 May; 99(5):367-74. PubMed ID: 10870325
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein C-III SstI genotypes modulate exercise-induced hypotriglyceridemia.
Woo SK; Kang HS
Med Sci Sports Exerc; 2004 Jun; 36(6):955-9. PubMed ID: 15179164
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia.
Buzza M; Fripp Y; Mitchell RJ
Ann Hum Biol; 2001; 28(5):481-90. PubMed ID: 11572515
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
[TBL] [Abstract][Full Text] [Related]
14. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.
Dammerman M; Sandkuijl LA; Halaas JL; Chung W; Breslow JL
Proc Natl Acad Sci U S A; 1993 May; 90(10):4562-6. PubMed ID: 8099442
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.
Chhabra S; Narang R; Lakshmy R; Vasisht S; Agarwal DP; Srivastava LM; Manchanda SC; Das N
Mol Cell Biochem; 2004 Apr; 259(1-2):59-66. PubMed ID: 15124908
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
[TBL] [Abstract][Full Text] [Related]
17. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
[TBL] [Abstract][Full Text] [Related]
18. Deoxyribonucleic acid (DNA) polymorphism in the apolipoprotein AI gene: a study in a Japanese population.
Aburatani H; Matsumoto A; Itoh H; Murase T; Takaku F; Itakura H
Jpn J Med; 1988 Feb; 27(1):56-9. PubMed ID: 2896804
[TBL] [Abstract][Full Text] [Related]
19. Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.
Xu CF; Nanjee MN; Savill J; Talmud PJ; Angelico F; Del Ben M; Antonini R; Mazzarella B; Miller N; Humphries SE
Am J Hum Genet; 1990 Sep; 47(3):429-39. PubMed ID: 1975478
[TBL] [Abstract][Full Text] [Related]
20. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls.
Xu CF; Angelico F; Del Ben M; Humphries S
Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
